The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors
Abstract
In the current study, we examined the types and frequency of KIT mutations in mast cell tumors from 191 dogs. Sequencing of reverse transcription-PCR products revealed alterations in 50 (26.2%) of the dogs. Most mutations were in exon 11 (n = 32), and of these, most were internal tandem duplications (n = 25) between residues 571 and 590. Within exon 11, there were two hotspots for mutations at codons 555-559 and 571-590. In addition, nine dogs had mutations in exon 8 and eight had mutations in exon 9. We selected the two most common mutants and two representative exon 11 mutants for further analysis. When expressed in Ba/F3 cells, they were constitutively tyrosine phosphorylated and induced growth factor–independent cell proliferation. AG1296, a tyrosine kinase inhibitor, dose dependently inhibited both the tyrosine phosphorylation of these mutants and their induction of growth factor–independent proliferation. This study shows that activating mutations in not only exon 11 but also exons 8 and 9 are common in canine mast cell tumors. These results also show that Ba/F3 cells can be used for the direct characterization of canine KIT mutants, eliminating the need to make equivalent mutations in the mouse or human genes. (Mol Cancer Res 2008;6(7):1137–45)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ba/F3 cells and their use in kinase drug discovery
Warmuth, M., Kim, S., Gu, X.-J., Xia, G., & Adrián, F. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328011a25f · Cited by 240
Cited by
London, C. A., Malpas, P. B., Wood-Follis, S. L., Boucher, J. F., Rusk, A. W., Rosenberg, M. P., Henry, C. J., Mitchener, K. L., Klein, M. K., Hintermeister, J. G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1860 · Cited by 424
Masitinib is Safe and Effective for the Treatment of Canine Mast Cell Tumors
Hahn, K. A., Oglivie, G., Rusk, T., Devauchelle, P., Leblanc, A., Legendre, A., Powers, B., Leventhal, P. S., Kinet, J.-P., Palmerini, F., et al. (2008) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2008.0190.x · Cited by 289
Self-citationEuropean consensus document on mast cell tumours in dogs and cats
Blackwood, L., Murphy, S., Buracco, P., De Vos, J. P., De Fornel‐Thibaud, P., Hirschberger, J., Kessler, M., Pastor, J., Ponce, F., Savary-Bataille, K., et al. (2012) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2012.00341.x · Cited by 268
The telomere/telomerase system in autoimmune and systemic immune-mediated diseases
Georgin-Lavialle, S., Aouba, A., Mouthon, L., Londono-Vallejo, J. A., Lepelletier, Y., Gabet, A.-S., & Hermine, O. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.04.004 · Cited by 97
Self-citation
Metadata
- Authors
- Letard, S., Yang, Y., Hanssens, K., Palmérini, F., Leventhal, P. S., Guéry, S., Moussy, A., Kinet, J.-P., Hermine, O., & Dubreuil, P.
- Venue
- Molecular Cancer Research
- Published
- 2008-07-01
- Volume
- 6
- Issue
- 7
- Pages
- 1137-1145
- ISSN
- 1541-7786 (ISSN-L)
- 1557-3125
- OpenAlex
- W2142654069
- Cited by
- 185
- References
- 1
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-08-0067
- The paper
- Letard, S., Yang, Y., Hanssens, K., Palmérini, F., Leventhal, P. S., Guéry, S., Moussy, A., Kinet, J.-P., Hermine, O., & Dubreuil, P. (2008). Gain-of-Function Mutations in the Extracellular Domain of KIT Are Common in Canine Mast Cell Tumors. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-08-0067
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.